You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Best Practice
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 18, 2023

Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8, Stage III Bladder Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Stage I Bladder Cancer AJCC v8
  • +4 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Lymphadenectomy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Los Angeles

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Quality-of-Life Assessment
  • Vascularized Autograft
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jul 15, 2022

Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

Recruiting
  • Bladder Carcinoma
  • +7 more
  • Atezolizumab
  • +5 more
  • Toronto, Ontario, Canada
    University Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022

Addressing Barriers to Palliative Care Use in Bladder Cancer

Completed
  • Muscle-Invasive Bladder Carcinoma
  • +3 more
  • Surveys
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

Not yet recruiting
  • Recurrent Bladder Carcinoma
  • +2 more
  • Pharmacokinetic Study
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Bladder Cancer Stage II Trial in Los Angeles (MRI imaging of the pelvis/bladder, genomic analysis of tumor)

Recruiting
  • Bladder Cancer Stage II
  • MRI imaging of the pelvis/bladder
  • genomic analysis of tumor
  • Los Angeles, California
    Cedars-Sinai Medical Center
Sep 27, 2022

Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,

Recruiting
  • Stage II Bladder Cancer AJCC v8
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial

Not yet recruiting
  • Muscle Invasive Bladder Urothelial Carcinoma
  • +3 more
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Aug 10, 2023

Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

Active, not recruiting
  • Hydronephrosis
  • +18 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

Terminated
  • Bladder Cancer
  • +4 more
  • 3D conformal radiation therapy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 14, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)

Recruiting
  • Stage II Breast Cancer
  • +22 more
  • Behavioral Intervention
  • Bay City, Michigan
  • +7 more
Sep 29, 2021

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,

Terminated
  • Infiltrating Bladder Urothelial Carcinoma
  • +9 more
  • Cytology Specimen Collection Procedure
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 15, 2021

Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)

Completed
Has Results
  • Bladder Cancer
  • induction cisplatin
  • +13 more
  • Atlanta, Georgia
  • +10 more
May 23, 2022

Urothelial Carcinoma, Bladder Cancer Trial in Zhengzhou (Toripalimab, Gemcitabine)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Nov 24, 2021

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +13 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 8, 2022

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022